Javascript must be enabled to continue!
Personalized algorithm for predicting the formation of bronchiectasis in patients with chronic mucopurulent bronchitis
View through CrossRef
Introduction. Chronic bronchitis is the most common chronic lung disease. The main problem of this disease is late diagnosis due to mild clinical symptomatology and untimely application of patients for medical help. One tool to solve this problem is the search of predictors of bronchiectasis development in patients with chronic mucopurulent bronchitis.Aim: To optimize the prediction of bronchiectasis formation in patients with chronic mucopurulent bronchitis.Material and Methods. Observation of 92 patients with chronic mucopurulent bronchitis was carried out and an attempt to predict bronchiectasis formation in them after 12 months of observation was made. The course of chronic mucopurulent bronchitis was assessed after 12 months. The main group was divided into two subgroups depending on the development of bronchiectasis according to chest computed tomography (CCT). The content of circulating annexin V mononuclear cells at different stages of apoptosis of circulating annexin V mononuclear cells and the neutrophil-lymphocyte index (NLI) were determined.Results. To develop a personalized prediction of the probability of bronchiectasis formation in patients with chronic mucopurulent bronchitis after 12 months, the studied biomarkers were analyzed and the dynamics of these biomarkers were assessed after 12 months of observation (second control point). Increasing the probability of bronchiectasis development in patients with chronic mucous-purulent bronchitis according to the results of the study are: increase in the value of neutrophil-lymphocytic index at exacerbation of chronic mucous-purulent bronchitis by 1 increases the risk of bronchiectasis formation in 57,136. The presence of association of microbial agents increases the risk of bronchiectasis formation by 57,077 times. Increase in the specific weight (%) of circulating annexin V mononuclear cells at the early stage of apoptosis at the beginning of exacerbation by 1% increases the risk of bronchiectasis formation by 4,982 times, increase in disease duration by 1 year increases the risk by 1,633 times.Conclusion. The obtained personalized algorithm for predicting the probability of bronchiectasis formation in patients with chronic mucopurulent bronchitis has high sensitivity and specificity – 96,6% and 98,4%, respectively.
Cardiology Research Institute
Title: Personalized algorithm for predicting the formation of bronchiectasis in patients with chronic mucopurulent bronchitis
Description:
Introduction.
Chronic bronchitis is the most common chronic lung disease.
The main problem of this disease is late diagnosis due to mild clinical symptomatology and untimely application of patients for medical help.
One tool to solve this problem is the search of predictors of bronchiectasis development in patients with chronic mucopurulent bronchitis.
Aim: To optimize the prediction of bronchiectasis formation in patients with chronic mucopurulent bronchitis.
Material and Methods.
Observation of 92 patients with chronic mucopurulent bronchitis was carried out and an attempt to predict bronchiectasis formation in them after 12 months of observation was made.
The course of chronic mucopurulent bronchitis was assessed after 12 months.
The main group was divided into two subgroups depending on the development of bronchiectasis according to chest computed tomography (CCT).
The content of circulating annexin V mononuclear cells at different stages of apoptosis of circulating annexin V mononuclear cells and the neutrophil-lymphocyte index (NLI) were determined.
Results.
To develop a personalized prediction of the probability of bronchiectasis formation in patients with chronic mucopurulent bronchitis after 12 months, the studied biomarkers were analyzed and the dynamics of these biomarkers were assessed after 12 months of observation (second control point).
Increasing the probability of bronchiectasis development in patients with chronic mucous-purulent bronchitis according to the results of the study are: increase in the value of neutrophil-lymphocytic index at exacerbation of chronic mucous-purulent bronchitis by 1 increases the risk of bronchiectasis formation in 57,136.
The presence of association of microbial agents increases the risk of bronchiectasis formation by 57,077 times.
Increase in the specific weight (%) of circulating annexin V mononuclear cells at the early stage of apoptosis at the beginning of exacerbation by 1% increases the risk of bronchiectasis formation by 4,982 times, increase in disease duration by 1 year increases the risk by 1,633 times.
Conclusion.
The obtained personalized algorithm for predicting the probability of bronchiectasis formation in patients with chronic mucopurulent bronchitis has high sensitivity and specificity – 96,6% and 98,4%, respectively.
Related Results
Upper Extremity Exercise Capacity and Activities of Daily Living in Individuals with Bronchiectasis Versus Healthy Controls
Upper Extremity Exercise Capacity and Activities of Daily Living in Individuals with Bronchiectasis Versus Healthy Controls
Abstract
Objective
The purpose of this study was to compare the upper extremity exercise capacity and activities of daily living...
Endotyping Chronic Obstructive Pulmonary Disease, Bronchiectasis, and the “Chronic Obstructive Pulmonary Disease–Bronchiectasis Association”
Endotyping Chronic Obstructive Pulmonary Disease, Bronchiectasis, and the “Chronic Obstructive Pulmonary Disease–Bronchiectasis Association”
Abstract
Rationale
Bronchiectasis and chronic obstructive pulmonary disease (COPD) are two disease entities with overlapp...
2004 chronic obstructive pulmonary disease with and without bronchiectasis in Aboriginal Australians: a comparative study
2004 chronic obstructive pulmonary disease with and without bronchiectasis in Aboriginal Australians: a comparative study
AbstractBackgroundChronic respiratory disorders are highly prevalent in Aboriginal Australian population, including chronic obstructive pulmonary disease (COPD) and bronchiectasis....
The clinical impact of presence and onset time of bronchiectasis on asthmatic patients
The clinical impact of presence and onset time of bronchiectasis on asthmatic patients
Abstract
Background:
Bronchiectasis is a complex disorder that can arise from asthma and other reasons; patients with asthma an...
Evaluation of effects of bronchiectasis on bronchial artery diameter with multidetector computed tomography
Evaluation of effects of bronchiectasis on bronchial artery diameter with multidetector computed tomography
Background: Among patients with increased bronchial artery diameter there is a significant association between hemoptysis and bronchiectasis score. The higher score of bronchiectas...
A systematic review to determine the presence and effectiveness of shared decision making interventions for airway clearance techniques in adults with bronchiectasis
A systematic review to determine the presence and effectiveness of shared decision making interventions for airway clearance techniques in adults with bronchiectasis
Background Bronchiectasis is a chronic lung disorder, impaired muco-ciliary clearance and sputum retention are core elements in bronchiectasis pathophysiology. Airway clearance is ...
Exploring Immune Dysfunction in Bronchiectasis: A Focus on Natural Killer Cells using Single-Cell Transcriptomes
Exploring Immune Dysfunction in Bronchiectasis: A Focus on Natural Killer Cells using Single-Cell Transcriptomes
Abstract
Bronchiectasis describes chronic airway inflammation involving various immune cells; however, little information is available regarding cell-type-specific pathogen...
Clinical and spirometric characteristics of patients with asthma and bronchiectasis: a comparative observational study
Clinical and spirometric characteristics of patients with asthma and bronchiectasis: a comparative observational study
Abstract
Background
Bronchiectasis is a heterogeneous condition that may coexist with asthma and has been associated with...

